INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

18,927 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
CL
Chapman Steven LeonardDirector, CEO AND PRESIDENT
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$366K
914 sh
Nov 2, 2026
Page 29 of 474
← PrevNext →
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

19
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$316K
760 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$245K
9,527 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$414K
16.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$399K
16.8K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
SR
Swanson Luke RoyCHIEF TECHNOLOGY OFFICER
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
7,027 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

19
AO
Atay OguzhanDirector, Chairman and CEO
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$225K
2,075 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$1.96M
56.0K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

19
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
633 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$399K
16.8K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

19
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$414K
16.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
JH
Jordan Joseph HughDirector, Chief Executive Officer
DPZDOMINOS PIZZA INC
Open-market sale · 10b5-1 plan
SELL$1.54M
4,870 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$51K
3,300 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

18
SC
Syrvalin Kristine CEVP General Counsel
MTUSMetallus Inc.
Open-market sale · 10b5-1 plan
SELL$102K
4,643 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$86K
2,393 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$101K
2,816 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
PC
Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1.80M
20.0K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

18
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Open-market sale · 10b5-1 plan
SELL$43K
600 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

18
OJ
O Connor Kevin JDirector
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$6,713
110 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

18
FL
Felice Laura L.EVP, Chief Financial Officer
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$353K
3,241 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$251K
2,320 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
AO
Atay OguzhanDirector, Chairman and CEO
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$434K
4,009 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Open-market sale · 10b5-1 plan
SELL$92K
1,295 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Open-market sale
SELL$8,738
660 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
AR
Anderson RaymondDirector
MNPRMonopar Therapeutics
Open-market sale · 10b5-1 plan
SELL$56K
840 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
WY
Wassenaar YvonneDirector
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
721 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
PE
Palmer Benjamin EdwardSVP, Pres Commercial
VSATVIASAT INC
Open-market sale · 10b5-1 plan
SELL$154K
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$8.81M
174.9K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
HL
Hendry Gregory LChief Accounting Officer
PMTPennyMac Mortgage Investment Trust
Open-market sale · 10b5-1 plan
SELL$19K
2,443 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.34M
29.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
SF
Stat Lauren Elaina FriedmanDirector
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$253K
1,358 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$3.06M
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$6.71M
133.3K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

16
SR
Swanson Luke RoyCHIEF TECHNOLOGY OFFICER
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$212K
3,283 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$172K
6,700 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
BJ
Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$357K
1,160 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$81K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
DM
Daspit MarisaCHIEF PEOPLE OFFICER
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
720 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$118K
295 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K